Management Team

Shu-Ichi Kanazashi, M.D., Ph.D. President & CEO

Shu-Ichi Kanazashi, M.D., Ph.D. was elected President and Chief Executive Officer of UMN Pharma in November of 2007 after serving as the Chief Medical Officer since 2005. Prior to joining UMN Pharma, Dr. Kanazashi was the Executive Officer & Chief Scientific Officer of Shin-Nippon Biomedical Laboratories Ltd. Previously, he was employed by Nippon Roche K.K. and Sony Corporation. As a diplomat of the Japan Pediatric Society and the Japanese Society of Allergology, he was engaged in clinical practice at various hospitals in Japan. Dr. Kanazashi received an M.D. and Ph.D. degree in medical science from Kyoto University. He completed his research fellowships in immunology at Harvard Medical School/ Massachusetts General Hospital.

Tatsuyoshi Hirano Director

Tsuyoshi Teshima Director

Fumihisa Nakata Director

Masahiro Michishita, M.D., Ph.D. Director

Masaharu Ito, Ph.D. Independent Director

Jun-Ichi Takagi Auditor

Hisamitsu Kato Independent　Auditor

Yoshinobu Kato Independent　Auditor